BioCore Receives Emergency Use Authorization for COVID-19 Diagnostic Kit... Sixth in Korea
[Asia Economy Reporter Oh Ju-yeon] BioCore announced on the 11th that its COVID-19 diagnostic kit product, 'BioCore 2019-nCoV Real-Time PCR Kit,' has received emergency use authorization from the Ministry of Food and Drug Safety.
This is the sixth time a COVID-19 diagnostic kit has received emergency use approval in South Korea.
The BioCore diagnostic kit diagnoses COVID-19 using a real-time gene amplification method.
Hot Picks Today
"Now Our Salaries Are 10 Million Won a Month" Record High... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- "Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"
- While All Eyes Were on Samsung and Hynix, This Company Surged 50% to New Highs in Four Days [Weekend Money]
- "Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
- Experts Already Watching Closely..."Target Price Set at 970,000 Won" Only Upward Momentum Remains [Weekend Money]
Prior to this approval, the product obtained export permission from the Ministry of Food and Drug Safety and is being exported to over 20 countries including Germany, Italy, Spain, India, and Ghana.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
